Effectiveness of Extra-corporeal Shockwave Diathermy in the Management of Upper Limb Function Patients With Stroke.
Effectiveness of Extra-corporeal Shockwave Diathermy in the Management of Upper Limb Function Patients With Stroke: Randomized Controlled Trial.
- Stroke
At a glance
- Phase
- Phase not stated
- Study type
- Interventional
- Sponsor
- Gulf Medical University
- Enrolment target
- 50
- Started
- 30 October 2025
- Main results due
- 28 February 2027
- Study sites
- 1
- Registry updated
- 24 September 2026
Can you take part?
- Ages 18 years to 65 years.
- Open to any sex.
- You need the condition being studied — healthy volunteers are not accepted.
These are the headline rules only. Every study has a longer list, and whether you are eligible is decided by the research team at the site — never by this page.
Read the full eligibility criteria
Inclusion criteria: 1. Diagnosed as 1st stroke incidence 6 months back 2. Both male and female 3. Age 25 to 65 years 4. the ability to follow verbal instructions 5. Modified Ashworth Scale score 1-4 Exclusion criteria: 1. Recurrent stroke. 2. Severe contractures or deformities of upper extremity. 3. Chronic pain affecting upper extremity function. 4. malignant tumor, pacemakers, infection
What this study is about
In the sponsor’s own words, from the registry.
Stroke is a leading cause of death and disability worldwide. A major complication of stroke is spasticity, marked by increased muscle tone and impaired movement. It affects majority stroke patients and complicates rehabilitation, affecting the upper limb function of survivors.
While traditional treatments like oral medications and botulinum toxin injections offer some relief, they have notable limitations, causing the need for novel, non-invasive approaches. Extracorporeal shock wave therapy (ESWT), which uses acoustic waves for regeneration and neuromodulation, has shown promise in reducing spasticity with minimal side effects, though its precise mechanisms and ideal protocols need further study. Current evidence supports ESWT's efficacy and safety, often matching established treatments, but gaps remain regarding standardized application and long-term functional outcomes, highlighting the need for more robust research.
Study sites(1)
Gulf Medical University
Ajman, Ajman Emirate, United Arab Emirates
Recruiting
Showing 1 of 1 sites. 1 of the 1 site on this study is recruiting right now — a site can stop enrolling while the study as a whole is still open.
Source: ClinicalTrials.gov record NCT07520032. Trialion does not run this study, is not paid to refer anyone to it, and cannot enrol you. Eligibility is always decided by the research team at the site.
Not the right study?
Answer three questions and see the studies recruiting near you, in plain language.
Find a study for me